Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 3/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.54 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL16296636 | 0.98 | SLC18A3 (0.52) | SLC18A3SIGMAR1GRIN2BDRD2TSHR | |
| SCHEMBL19094052 | 0.91 | SLC18A3 (0.47) | SLC18A3SIGMAR1TSHRGAAMAPT | |
| SCHEMBL19539969 | 0.89 | SLC18A3 (0.46) | SLC18A3SIGMAR1TSHRGAAMAPT | |
| SCHEMBL7943971 | 0.87 | NPC1 (0.55) | SLC18A3SIGMAR1GAAKDM1AMAOB | |
| SCHEMBL23050200 | 0.86 | SLC18A3 (0.45) | SLC18A3SIGMAR1GRIN2BTSHRGAA | |
| SCHEMBL2479517 | 0.86 | SLC18A3 (0.45) | SLC18A3SIGMAR1GRIN2BTSHRGAA | |
| SCHEMBL190417 | 0.81 | SLC18A3 (0.67) | SLC18A3SIGMAR1GRIN2BDRD2GAA | |
| SCHEMBL41763 | 0.81 | — | — | |
| SCHEMBL4483396 | 0.80 | SLC18A3 (0.69) | SLC18A3SIGMAR1GRIN2BTSHRKDM1A | |
| SCHEMBL20499599 | 0.79 | HPGD (0.53) | TSHRGAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118136967-B | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118136967-A | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| EP-4165033-A1 | SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF | Betta Pharmaceuticals Co., Ltd (CN) | 2023-04-19 | — | — | EP | claimed |
| WO-2021249449-A1 | SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2021-12-16 | — | — | WO | claimed |
| WO-2020210428-A1 | NOVEL INHIBITORS OF FLAVIVIRUS PROTEASE FOR PREVENTION AND TREATMENT OF ZIKA, DENGUE AND OTHER FLAVIVIRUS INFECTIONS | BAYLOR COLLEGE OF MEDICINE (US) | 2020-10-15 | — | — | WO | claimed |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | ANIMA BIOTECH INC. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2025-04-03 | — | — | US | disclosed |
| CN-118136967-B | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-118136967-A | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117813154-A | Polyamide-based microcapsules | 弗门尼舍有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023117914-A1 | CYCLOPENTATHIOPHENE CARBOXAMIDE DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| US-20230167447-A1 | Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof | GENETIC INTELLIGENCE INC (US) | 2023-06-01 | — | — | US | disclosed |
| EP-1465008-B1 | Silver halide photographic light-sensitive material | FUJIFILM CORP (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-20070197624-A1 | Acylated amino acid amidyl pyrazoles and related compounds | ELAN PHARMACEUTICALS, INC. (US) | 2007-08-23 | — | — | US | disclosed |
| EP-1633350-A2 | ACYLATED AMINO ACID AMIDYL PYRAZOLES AND RELATED COMPOUNDS | Elan Pharmaceuticals, Inc. (US) | 2006-03-15 | — | — | EP | disclosed |
| WO-2005009344-A2 | ACYLATED AMINO ACID AMIDYL PYRAZOLES AND RELATED COMPOUNDS | ELAN PHARMACEUTICALS, INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| EP-0294220-B1 | Photopolymerizable composition | HITACHI CHEMICAL CO LTD (JP) | 1994-05-25 | — | — | EP | disclosed |
| US-5034429-A | An unsaturated monomer, a photoinitiator and a benzene derivative for providing a cured film | HITACHI CHEMICAL CO., LTD. (JP) | 1991-07-23 | — | — | US | disclosed |
| EP-0294220-A2 | Photopolymerizable composition | Hitachi Chemical Co., Ltd. (JP) | 1988-12-07 | — | — | EP | disclosed |
| US-4078076-A | HYPOLIPEMIC ACTIVITY | ROUSSEL UCLAF (FR) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167447-A1 | Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof | FNIP1, FN1, TNNC1 | SLC18A3 3295/4885SIGMAR1 4838/4885GRIN2B 1845/4885 |
| US-20070197624-A1 | Acylated amino acid amidyl pyrazoles and related compounds | APP, BACE1, APH1A | SLC18A3 414/4885SIGMAR1 4323/4885GRIN2B 461/4885 |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | MYC, MYCBP, MYCBP2 | SLC18A3 4567/4885SIGMAR1 3591/4885GRIN2B 4630/4885 |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | MYC, MYCBP, MYCBP2 | SLC18A3 4567/4885SIGMAR1 3591/4885GRIN2B 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.